Skip to content

Breast Cancer Health Center

Font Size

Genetics of Breast and Ovarian Cancer (PDQ®): Genetics - Health Professional Information [NCI] - Psychosocial Issues in Inherited Breast and Ovarian Cancer Syndromes

Table 14. Uptake of Risk-reducing Mastectomy (RRM) and/or Breast Screening AmongBRCA1andBRCA2Mutation Carriers

Study CitationStudy PopulationUptake of RRMUptake of Breast Screening Mammography and/or Breast MRILength of Follow-upComments
MRI = magnetic resonance imaging; RRSO = risk-reducing salpingo-oophorectomy.
a Self-report as data source.
b Medical records as data source.
United States
Botkin et al. (2003)[216]Carriers (n = 37)aCarriers 0%Mammography24 mo
- Carriers 57%
Noncarriers (n = 92)aNoncarriers 0%- Noncarriers 49%
- Declined test 20%
Declined testing (n = 15)aMRI
- Not evaluated
Beattie et al. (2009)[217]Carriers (n = 237)bCarriers 23%Not applicableMean, 3.7 yWomen opting for RRM were younger than 60 y, had a prior diagnosis of breast cancer, and also underwent RRSO.
Median time to RRM: 124 days from receiving results.
O'Neill et al. (2010)[218]Carriers (n = 146)aCarriers 13%Not applicable12 moIntentions at test result disclosure predicted RRM decisions.
Schwartz et al. (2012)[219]Carriers (n = 108)aCarriers 37%MammographyMean, 5.3 yPredictors of RRM were younger age, higher precounseling cancer distress, more recent diagnosis of breast or ovarian cancer, and intact ovaries.
- Carriers affected 92%
- Carriers unaffected 82%
Noncarriers (n = 60)aNoncarriers 0%- Noncarriers 66%
- Uninformative affected 89%
Uninformative (n = 206)aUninformative 6.8%- Carriers affected 51%
- Carriers unaffected 46%
- Noncarriers 11%
- Uninformative 27%
Garcia et al. (2013)[220]Carriers (n = 250)bCarriers 44%Excluding women post RRM:41 months; range, 26-66 moBreast surveillance decreased significantly from y 1-5 of follow-up: Mammography 43% to 7%; MRI 35% to 3%.
- Carriers 43%
- Carriers 35%
Singh et al. (2013)[221]Carriers (n = 136)bCarriers 42%Not applicableRange, 1-11 yPredictors of RRM were first- or second-degree relative diseased from breast cancer, having had at least one childbirth, and having undergone testing after 2005.
Phillips et al. (2006)[222]Carriers (n = 70)aCarriers 11%Mammography3 y
- Carriers 89%
- Not evaluated
Metcalfe et al. (2008)[223]Carriers (N = 2,677)aCarriers 18% (unaffected)Mammography3.9 y; range, 1.5-10.3 yLarge differences in uptake of risk management options by country.
- Carriers 87%
MRI1,294 participants had a personal history of breast cancer.
- Carriers 31%
Julian-Reynier et al. (2011)[224]Carriers (n = 101)aCarriers 6.9%Mammography5 yNoncarriers often continued screening.
- Carriers 59%
- Noncarriers aged 30-39 y 53%
Noncarriers (n = 145)aNoncarriers 0%MRI
- Carriers 31%
- Noncarriers 4.8%
Next Article:

Today on WebMD

Breast Cancer Overview
From self-exams and biopsies to reconstruction, we’ve got you covered.
Dealing with breast cancer
Get answers to your questions.
woman having mammogram
Experts don’t agree on all fronts, but you can be your own advocate.
woman undergoing breast cancer test
Many women worry. But the truth? Most abnormalities aren’t breast cancer.
Breast Cancer Treatments Improving
Resolved To Quit Smoking
Woman getting mammogram
Screening Tests for Women
ovarian cancer overview slideshow
serious woman
what is your cancer risk
10 Ways to Revitalize Slideshow